In today's era of cell, gene, and tissue therapies, new treatments are truly game-changing, often creating an opportunity for a healthy, normal life for people who previously had no options
The biopharma industry faces a relentless demand for evidence of real-world effectiveness (RWE), safety, and value throughout the product lifecycle to complement the clinical trial-based be
It’s no wonder the cell and gene therapy (CAGT) market is piquing interest from the broader healthcare ecosystem by offering hope to patients where traditional treatments may have fallen sh
